Time to Discontinuation on Darolutamide Longer in nmCRPC
August 10th 2023Alicia K. Morgans, MD, MPH, discusses real-world evidence the shows patients with non-metastatic castration resistant prostate cancer on darolutamide have a longer time till discontinuation when compared with enzalutamide and apalutamide.
Watch